August 2023 EMA Primary Endpoint Qualification of Stride Velocity 95th Centile (SV95C) for Duchenne Muscular Dystrophy
June 2023 Sysnav Healthcare is participating in the upcoming Rare Disease Endpoint Advancement Pilot Program Workshop.
April 2023 Collaborative Article: “Evolving regulatory perspectives on digital health technologies for medicinal product development”